Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas

@article{Dalloglio2008DoseintensityTA,
  title={Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas},
  author={S. Dall'oglio and A. D'Amico and F. Pioli and M. Gabbani and F. Pasini and M. G. Passarin and A. Talacchi and S. Turazzi and S. Maluta},
  journal={Journal of Neuro-Oncology},
  year={2008},
  volume={90},
  pages={315-319}
}
Purpose We performed a new phase II trial enrolling patients with newly diagnosed high-grade glioma (HGG) to test the efficacy of a weekly alternating temozolomide (TMZ) schedule after surgery and concomitant chemoradiotherapy. Methods From January 2005 to January 2007, 34 patients (21 men, 13 women; age range 30–70, mean age 53) were enrolled. There were 32 glioblastoma multiforme and two anaplastic astrocytoma. Each patient after surgery received standard concurrent chemoradiotherapy. After a… Expand
18 Citations
Chemotherapy in glioma.
Unmet needs in the treatment of glioblastoma
Advances in drug delivery technology for the treatment of glioblastoma multiforme.
...
1
2
...

References

SHOWING 1-10 OF 17 REFERENCES
Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.
  • A. Wick, J. Felsberg, +7 authors W. Wick
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2007
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.
Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours.
Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.
  • E. Wong, K. Hess, +5 authors W. Yung
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1999
Methylguanine methyltransferase testing in glioblastoma: when and how?
  • R. Stupp, M. Hegi
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2007
...
1
2
...